Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REconsidering Long-TErm ASpirin in the Elderly in Secondary Prevention of Coronary Artery Disease (RELEASE) Norway: A Randomised, Registry-based Trial

NCT07854795 is registered in ClinicalTrials.gov with Vestre Viken Hospital Trust as lead sponsor.

NCT NCT07854795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07854795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REconsidering Long-TErm ASpirin in the Elderly in Secondary Prevention of Coronary Artery Disease (RELEASE) Norway: A Randomised, Registry-based Trial
Lead sponsor
Vestre Viken Hospital Trust
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 1, 2027
Completion date
December 1, 2031
Enrollment
7,000 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arterial disease (cad)